Benzinga | Dec 13, 2021 09:31AM EST

Jefferies Maintains Buy on IGM Biosciences, Raises Price Target to $126

Jefferies analyst Chris Howerton maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $101 to $126.